KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Current Taxes (2017 - 2020)

Aquestive Therapeutics has reported Current Taxes over the past 4 years, most recently at $316000.0 for Q4 2020.

  • Quarterly results put Current Taxes at $316000.0 for Q4 2020, up 5.33% from a year ago — trailing twelve months through Dec 2020 was $316000.0 (up 5.33% YoY), and the annual figure for FY2020 was $316000.0, up 5.33%.
  • Current Taxes for Q4 2020 was $316000.0 at Aquestive Therapeutics, down from $370000.0 in the prior quarter.
  • Over the last five years, Current Taxes for AQST hit a ceiling of $388000.0 in Q4 2018 and a floor of $176000.0 in Q2 2019.
  • Median Current Taxes over the past 4 years was $327000.0 (2018), compared with a mean of $312500.0.
  • Biggest five-year swings in Current Taxes: plummeted 33.08% in 2019 and later increased 5.33% in 2020.
  • Aquestive Therapeutics' Current Taxes stood at $372000.0 in 2017, then increased by 4.3% to $388000.0 in 2018, then fell by 22.68% to $300000.0 in 2019, then grew by 5.33% to $316000.0 in 2020.
  • The last three reported values for Current Taxes were $316000.0 (Q4 2020), $370000.0 (Q1 2020), and $300000.0 (Q4 2019) per Business Quant data.